Considerations on nonclinical studies for immunotoxicity of monoclonal antibodies / 药物评价研究
Drug Evaluation Research
;
(6): 1248-1253, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-664678
ABSTRACT
Most monoclonal antibodies (mAbs) can induce immune responses.For immunomodulatory mAbs,immunotoxicity is the major toxicity.This article summarizes the characteristics of immunotoxicity,the factors associated with immunotoxicity,and the general considerations of nonclinical studies and evaluations.Before the clinical trials,comprehensive nonclinical studies on immunotoxicityshould be step by step conductedbased on mAbs' characteristics.If needed,some additional studies should be conducted.Attention should be paid to combination of in vivo and in vitro studies,combination of animal species and humanex vivo cells,and multiple approaches for studies.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Drug Evaluation Research
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS